newsfilter
← Latest News
PR Newswire·

FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting

FSdC Spheroids Preserved Disc Height Better Than Any Other Fibroblast-Based Approach Tested in a 12-Week Rabbit Model of Degenerative Disc DiseaseHOUSTON, Oct. 19, 2026 /PRNewswire/ -- FibroBiologics, Inc. (NASDAQ:FBLG)